
Bath & Body Works (BBWI) valuation: assessing the stock after ongoing same-store sales weakness and declining EPS trends

I'm PortAI, I can summarize articles.
Bath & Body Works (BBWI) faces ongoing challenges with weak same-store sales and a projected 5% revenue drop, leading to a year-to-date share price decline of 47.8%. Despite trading at a steep discount, the stock's valuation is debated, with some seeing it as undervalued at $40.73. Key risks include lingering debt from the Victoria’s Secret split and slower international expansion. Investors are advised to consider both the potential rewards and risks.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

